World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03189329
Date of registration: 10/06/2017
Prospective Registration: No
Primary sponsor: Cengiz KAYA
Public title: The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients
Scientific title: The Effect of Retrobulbar Block on Bi-Hemispheric Cerebral Oxygen Saturation and Early Period Postoperative Cognitive Functions With Lidocaine and Levobupivacaine in Elderly Patients With Ophthalmic Surgery
Date of first enrolment: January 2015
Target sample size: 66
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03189329
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Investigator).  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Cengiz Kaya, MD
Address: 
Telephone:
Email:
Affiliation:  Ondokuz Mayis University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Undergoing vitreoretinal surgery (total duration < 60 minutes)

- The ASA (American Society of Anesthesiologists) Classification I-III

- Over the age of 60

- The patiens who had no cognitive dysfunction

Exclusion Criteria:

- Contraindication for retrobulbar block

- Preoperative systolic blood pressure of 180 mmHg, diastolic blood pressure of above
100 mmHg

- Uncontrolled diabetes

- Body mass index = 30 kg/m2

- MMSE = 24

- Advanced organ failure

- Hb < 9gr/dl



Age minimum: 60 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cognitive Function Abnormal
Vitreoretinal Surgery
Intraoperative Monitoring
Intervention(s)
Drug: 2% lidocaine hydrochloride
Drug: 0.5% levobupivacaine
Primary Outcome(s)
Cerebral oxygen saturation changes (rSO2) [Time Frame: The rSO2 value changes were recorded from baseline up to 40 minutes after surgery]
Secondary Outcome(s)
The akinesia score measurement [Time Frame: The akinesia score was assessed at the beginning of surgery till the first 15 min.]
The oxygen saturation (SpO2) measurement [Time Frame: The oxygen saturation (SpO2) was recorded from baseline up to 40 minutes after surgery]
Motor block onset time by eye movements score. [Time Frame: The motor block onset time was recorded at the beginning of surgery till the first 15 min]
The heart rate (HR) measurement [Time Frame: The heart rate (HR) was recorded from baseline up to 40 minutes after surgery]
The mean arterial pressure (MAP) measurement [Time Frame: The mean arterial pressure was recorded from baseline up to 40 minutes after surgery]
Patient satisfaction [Time Frame: Patient satisfaction was questioned 24 hours after surgery]
Motor block end time by eye movements score. [Time Frame: The motor block end time was recorded at the end of surgery till the first 24 h]
Sensory block end time by the conjunctival feeling score using the cotton contact test. [Time Frame: The sensory block end time was recorded at the end of surgery till the first 24 h]
Sensory block onset time by the conjunctival feeling score using the cotton contact test. [Time Frame: The sensory block onset time was recorded at the beginning of surgery till the first 15 min]
Cognitive function measurement [Time Frame: Cognitive functions were assessed from baseline up to 7 days after the surgery]
Surgeon satisfaction [Time Frame: Surgeon satisfaction was queried at the end of the surgery till the first 15 min.]
Secondary ID(s)
PYO.TIP.1904.15.009
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ondokuz Mayis University
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history